Cite
Challenges for Clinical Drug Development in Pulmonary Fibrosis.
MLA
White, Eric S., et al. “Challenges for Clinical Drug Development in Pulmonary Fibrosis.” Frontiers in Pharmacology, vol. 12, Jan. 2022, pp. 1–9. EBSCOhost, https://doi.org/10.3389/fphar.2022.823085.
APA
White, E. S., Thomas, M., Stowasser, S., & Tetzlaff, K. (2022). Challenges for Clinical Drug Development in Pulmonary Fibrosis. Frontiers in Pharmacology, 12, 1–9. https://doi.org/10.3389/fphar.2022.823085
Chicago
White, Eric S., Matthew Thomas, Susanne Stowasser, and Kay Tetzlaff. 2022. “Challenges for Clinical Drug Development in Pulmonary Fibrosis.” Frontiers in Pharmacology 12 (January): 1–9. doi:10.3389/fphar.2022.823085.